DE1252898B
(de)
|
1965-06-12 |
1967-10-26 |
Bayer Ag |
Verfahren zur Herstellung von Copolymerisaten des Trioxans
|
US5240928A
(en)
|
1989-07-03 |
1993-08-31 |
Merck & Co., Inc. |
Substituted quinazolinones as angiotensin II antagonists
|
DE3930262A1
(de)
|
1989-09-11 |
1991-03-21 |
Thomae Gmbh Dr K |
Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
KR910009330B1
(ko)
|
1989-10-23 |
1991-11-11 |
재단법인 한국화학연구소 |
항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
|
CA2037630C
(fr)
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Composes heterocycliques renfermant de l'azote, methode de production et applications correspondantes
|
US5470975A
(en)
|
1990-10-16 |
1995-11-28 |
E.R. Squibb & Sons, Inc. |
Dihydropyrimidine derivatives
|
US5290780A
(en)
|
1991-01-30 |
1994-03-01 |
American Cyanamid Co. |
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
|
US5238942A
(en)
|
1991-05-10 |
1993-08-24 |
Merck & Co., Inc. |
Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists
|
DE4121214A1
(de)
|
1991-06-27 |
1993-01-14 |
Bayer Ag |
7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
|
US5202322A
(en)
|
1991-09-25 |
1993-04-13 |
Merck & Co., Inc. |
Quinazolinone and pyridopyrimidine a-II antagonists
|
US5532243A
(en)
*
|
1992-02-14 |
1996-07-02 |
The Dupont Merck Pharmaceutical Company |
Antipsychotic nitrogen-containing bicyclic compounds
|
US5358951A
(en)
|
1993-04-23 |
1994-10-25 |
American Cyanamid Company |
Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones
|
DE4407047A1
(de)
|
1994-03-03 |
1995-09-07 |
Merck Patent Gmbh |
Acetamide
|
US20010016657A1
(en)
|
1997-03-18 |
2001-08-23 |
Smithkline Beecham P.L.C. |
Substituted isoquinoline derivatives and their use as anticonvulsants
|
CN1290251A
(zh)
|
1998-02-04 |
2001-04-04 |
万有制药株式会社 |
N-酰基环胺衍生物
|
JP2001039950A
(ja)
|
1999-07-30 |
2001-02-13 |
Banyu Pharmaceut Co Ltd |
N−アシル環状アミン誘導体
|
AU1244001A
(en)
|
1999-10-27 |
2001-05-08 |
Cor Therapeutics, Inc. |
Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
|
WO2002070523A1
(fr)
|
2001-03-07 |
2002-09-12 |
Pfizer Products Inc. |
Modulateurs de l'activite du recepteur de la chimiokine
|
CA2481313A1
(fr)
|
2002-04-12 |
2003-10-23 |
Merck & Co., Inc. |
Amides bicycliques
|
GB0303852D0
(en)
|
2003-02-19 |
2003-03-26 |
Pfizer Ltd |
Triazole compounds useful in therapy
|
WO2005023762A1
(fr)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Derives de pyrrolidine-2-carbonitrile et leur utilisation comme inhibiteurs de la dipeptidyle peptidase-iv (dpp-iv)
|
SE0302811D0
(sv)
|
2003-10-23 |
2003-10-23 |
Astrazeneca Ab |
Novel compounds
|
GB0324790D0
(en)
|
2003-10-24 |
2003-11-26 |
Astrazeneca Ab |
Amide derivatives
|
US7226951B2
(en)
|
2003-12-17 |
2007-06-05 |
Allergan, Inc. |
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
|
KR100610731B1
(ko)
|
2004-02-24 |
2006-08-09 |
한국과학기술연구원 |
T-형 칼슘 채널 차단제로서 유용한 3,4-디히드로퀴나졸린유도체 및 그의 제조 방법
|
JP4845873B2
(ja)
|
2004-03-03 |
2011-12-28 |
ケモセントリックス インコーポレーティッド |
二環式および架橋した窒素複素環
|
ES2297727T3
(es)
|
2004-06-09 |
2008-05-01 |
F. Hoffmann-La Roche Ag |
Derivados de octahidropirrolo(3,4-c)pirrol y su empleo como agentes antiviricos.
|
US7923554B2
(en)
|
2004-08-10 |
2011-04-12 |
Janssen Pharmaceutica N.V. |
HIV inhibiting 1,2,4-triazin-6-one derivatives
|
US7410949B2
(en)
|
2005-01-18 |
2008-08-12 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
|
GB0504019D0
(en)
|
2005-02-26 |
2005-04-06 |
Astrazeneca Ab |
Amide derivatives
|
MX2007013469A
(es)
|
2005-04-28 |
2008-01-22 |
Wyeth Corp |
Forma ii polimorfa de tanaproget.
|
US7737279B2
(en)
|
2005-05-10 |
2010-06-15 |
Bristol-Myers Squibb Company |
1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
|
TW200800999A
(en)
|
2005-09-06 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
PL1942108T3
(pl)
|
2005-10-28 |
2014-03-31 |
Ono Pharmaceutical Co |
Związek zawierający grupę zasadową i jego zastosowanie
|
ES2407115T3
(es)
|
2005-11-18 |
2013-06-11 |
Ono Pharmaceutical Co., Ltd. |
Compuesto que contiene un grupo básico y uso del mismo
|
JP2007176809A
(ja)
|
2005-12-27 |
2007-07-12 |
Hideaki Natsukari |
複素環置換アミド化合物、その製造法および医薬組成物
|
US20070208001A1
(en)
|
2006-03-03 |
2007-09-06 |
Jincong Zhuo |
Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
JP2008031064A
(ja)
*
|
2006-07-27 |
2008-02-14 |
Astellas Pharma Inc |
ジアシルピペラジン誘導体
|
JP5256202B2
(ja)
|
2006-09-11 |
2013-08-07 |
エム・エス・ディー・オス・ベー・フェー |
キナゾリノンおよびイソキノリノンアセトアミド誘導体
|
AR062790A1
(es)
|
2006-09-15 |
2008-12-03 |
Schering Corp |
Derivados de azetidina utiles en el tratamiento del dolor, diabetes y trastornos del metabolismo de los lipidos
|
US8735411B2
(en)
|
2006-10-02 |
2014-05-27 |
Abbvie Inc. |
Macrocyclic benzofused pyrimidine derivatives
|
TWI454262B
(zh)
|
2006-11-02 |
2014-10-01 |
Targacept Inc |
菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
|
ATE523497T1
(de)
|
2006-11-15 |
2011-09-15 |
High Point Pharmaceuticals Llc |
Neue 2-(2-hydroxyphenyl)benzimidazole, die sich für die behandlung von obesitas und diabetes eignen
|
TW200831085A
(en)
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Non-nucleoside reverse transcriptase inhibitors
|
EP1975165A1
(fr)
|
2007-03-27 |
2008-10-01 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Pyrrolidinamide substituée, sa fabrication et son utilisation en tant que médicament
|
JP2010522706A
(ja)
|
2007-03-29 |
2010-07-08 |
エフ.ホフマン−ラ ロシュ アーゲー |
非ヌクレオシド逆転写酵素阻害剤
|
CL2008001002A1
(es)
|
2007-04-11 |
2008-10-17 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
|
CN101663306A
(zh)
|
2007-04-27 |
2010-03-03 |
塞诺菲-安万特股份有限公司 |
2-杂芳基-吡咯并[3,4-c]吡咯衍生物及其作为scd抑制剂的用途
|
RU2483068C2
(ru)
|
2007-08-07 |
2013-05-27 |
Эбботт Гмбх Унд Ко.Кг |
Соединения хинолина, пригодные для лечения нарушений, являющихся ответом на модуляцию рецептора 5-ht6 серотонина
|
DE102007047737A1
(de)
|
2007-10-05 |
2009-04-30 |
Merck Patent Gmbh |
Piperidin- und Piperazinderivate
|
ES2830024T3
(es)
|
2007-10-19 |
2021-06-02 |
Novartis Ag |
Composiciones y métodos para el tratamiento del edema macular
|
US7935725B2
(en)
|
2007-10-31 |
2011-05-03 |
Janssen Pharmaceutica Nv |
Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
|
JP2009161449A
(ja)
|
2007-12-28 |
2009-07-23 |
Lion Corp |
Ppar活性促進剤並びに美容用飲食品、皮膚外用剤及び医薬
|
EP2301936A1
(fr)
|
2008-06-19 |
2011-03-30 |
Banyu Pharmaceutical Co., Ltd. |
Dérivé de spirodiamine-diarylcétoxime
|
WO2010028761A1
(fr)
|
2008-09-09 |
2010-03-18 |
Sanofi-Aventis |
Dérivés de 2-hétéro-aryl-pyrrolo[3, 4-c]pyrrol et leur utilisation en tant qu'inhibiteurs de scd
|
TW201020247A
(en)
|
2008-11-06 |
2010-06-01 |
Gruenenthal Gmbh |
Substituierte disulfonamide
|
CA2739725A1
(fr)
|
2008-11-17 |
2010-05-20 |
F. Hoffmann-La Roche Ag |
Acides naphtylacetiques employes en tant qu'antagonistes ou agonistes partiels de crth2
|
DE102008059578A1
(de)
|
2008-11-28 |
2010-06-10 |
Merck Patent Gmbh |
Benzo-Naphtyridin Verbindungen
|
EA201100879A1
(ru)
*
|
2008-12-01 |
2012-01-30 |
Мерк Патент Гмбх |
Производные пиридопиримидина в качестве ингибиторов аутотаксина
|
TW201035102A
(en)
|
2009-03-04 |
2010-10-01 |
Gruenethal Gmbh |
Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
|
CA2754446A1
(fr)
|
2009-03-05 |
2010-09-10 |
Daiichi Sankyo Company, Limited |
Derive de pyridine
|
WO2010108268A1
(fr)
|
2009-03-23 |
2010-09-30 |
Merck Frosst Canada Ltd. |
Composés hétérocycliques inhibiteurs de la stéaroyl-coenzyme a delta-9 désaturase
|
TW201038572A
(en)
|
2009-03-25 |
2010-11-01 |
Gruenenthal Gmbh |
Substituted spiro-amide compounds
|
MX2011010203A
(es)
*
|
2009-04-02 |
2011-10-14 |
Merck Patent Gmbh |
Derivados de piperidina y piperazina como inhibidores de autotaxina.
|
US8329907B2
(en)
*
|
2009-04-02 |
2012-12-11 |
Merck Patent Gmbh |
Autotaxin inhibitors
|
EA201101399A1
(ru)
|
2009-04-02 |
2012-08-30 |
Мерк Патент Гмбх |
Гетероциклические соединения в качестве ингибиторов аутотаксина
|
FR2945534B1
(fr)
*
|
2009-05-12 |
2012-11-16 |
Sanofi Aventis |
DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
|
WO2010135524A1
(fr)
|
2009-05-22 |
2010-11-25 |
Exelixis, Inc. |
Inhibiteurs de pi3k/mtor à base de benzoxazépines pour lutter contre les maladies prolifératives
|
WO2010141817A1
(fr)
|
2009-06-05 |
2010-12-09 |
Janssen Pharmaceutica Nv |
Modulateurs d'amide d'acide gras hydrolase de type diamine urée spirocyclique substituée par un groupe hétéroaryle
|
DE102009033392A1
(de)
*
|
2009-07-16 |
2011-01-20 |
Merck Patent Gmbh |
Heterocyclische Verbindungen als Autotaxin-Inhibitoren II
|
EP2462128B1
(fr)
|
2009-08-04 |
2016-09-21 |
Amira Pharmaceuticals, Inc. |
Composés en tant qu'antagonistes du récepteur de l'acide lysophosphatidique
|
UA107360C2
(en)
|
2009-08-05 |
2014-12-25 |
Biogen Idec Inc |
Bicyclic aryl sphingosine 1-phosphate analogs
|
AR079022A1
(es)
|
2009-11-02 |
2011-12-21 |
Sanofi Aventis |
Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
|
ES2534516T3
(es)
|
2010-01-07 |
2015-04-23 |
E.I. Du Pont De Nemours And Company |
Compuestos heterocíclicos fungicidas
|
WO2011115813A1
(fr)
|
2010-03-18 |
2011-09-22 |
Abbott Laboratories |
Acétamides de lactame en tant que bloqueurs des canaux calciques
|
SI2547679T1
(sl)
|
2010-03-19 |
2015-12-31 |
Pfizer Inc. |
Derivati 2,3 dihidro-1H-inden-1-il-2,7-diazaspiro(3.6)nonana in njihova uporaba kot antagonisti ali inverzni agonisti grelinskega receptorja
|
AU2011232058B2
(en)
|
2010-03-26 |
2016-09-08 |
Merck Patent Gmbh |
Benzonaphthyridinamines as autotaxin inhibitors
|
GB201008005D0
(en)
|
2010-05-13 |
2010-06-30 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
WO2011151461A2
(fr)
|
2010-06-04 |
2011-12-08 |
B.S.R.C. "Alexander Fleming" |
Modulation de la voie autotaxine et utilisations correspondantes
|
AR082590A1
(es)
|
2010-08-12 |
2012-12-19 |
Hoffmann La Roche |
Inhibidores de la tirosina-quinasa de bruton
|
CN103201262B
(zh)
|
2010-08-20 |
2016-06-01 |
艾米拉医药股份有限公司 |
自分泌运动因子抑制剂及其用途
|
US8859775B2
(en)
|
2010-09-02 |
2014-10-14 |
Merck Patent Gmbh |
Pyrazolopyridinone derivatives as LPA receptor antagonists
|
JP5699223B2
(ja)
|
2010-12-02 |
2015-04-08 |
シャンハイ デュァ ノボ ファルマテック カンパニー リミテッド |
複素環誘導体、その合成法および医療用途
|
CA2818903C
(fr)
|
2010-12-14 |
2021-03-23 |
Electrophoretics Limited |
5-(1,3-benzoxazol-2-yl)-4-(pyridine-4-yl)pyrimidine-2-amine et son utilisation comme inhibiteur de caseine kinase 1 delta
|
US9260416B2
(en)
*
|
2011-05-27 |
2016-02-16 |
Amira Pharmaceuticals, Inc. |
Heterocyclic autotaxin inhibitors and uses thereof
|
ES2609579T3
(es)
|
2011-08-29 |
2017-04-21 |
VIIV Healthcare UK (No.5) Limited |
Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH
|
WO2013054185A1
(fr)
|
2011-10-13 |
2013-04-18 |
Pfizer, Inc. |
Dérivés de pyrimidine et de pyridine utiles en thérapie
|
JPWO2013065712A1
(ja)
|
2011-10-31 |
2015-04-02 |
東レ株式会社 |
ジアザスピロウレア誘導体及びその医薬用途
|
US8809552B2
(en)
|
2011-11-01 |
2014-08-19 |
Hoffmann-La Roche Inc. |
Azetidine compounds, compositions and methods of use
|
JP5918859B2
(ja)
|
2011-12-02 |
2016-05-18 |
フェネックス ファーマシューティカルス アーゲー |
オーファン核内受容体RARに関連するオーファン受容体−ガンマ(RORγ、NR1F3)活性の調整剤としての、慢性の炎症性疾患および自己免疫性疾患を治療するためのピロロカルボキサミド
|
TWI638802B
(zh)
|
2012-05-24 |
2018-10-21 |
芬蘭商奧利安公司 |
兒茶酚o-甲基轉移酶活性抑制化合物
|
MA37756B1
(fr)
|
2012-06-13 |
2018-09-28 |
Hoffmann La Roche |
Nouveaux composés diazaspirocycloalcane et azaspirocycloalcane
|
ME03300B
(fr)
|
2012-06-13 |
2019-07-20 |
Incyte Holdings Corp |
Composés tricycliques substitués servant d'inhibiteurs des fgfr
|
RU2665462C2
(ru)
|
2012-06-27 |
2018-08-30 |
Ф. Хоффманн-Ля Рош Аг |
Соединения 5-азаиндазола и способы их применения
|
SG11201500339XA
(en)
|
2012-07-27 |
2015-02-27 |
Biogen Ma Inc |
Atx modulating agents
|
BR112015001613B1
(pt)
|
2012-07-27 |
2021-02-23 |
Biogen Ma Inc |
compostos que são agentes de modulação de s1p e/ou agentes de modulação de atx, seus usos e composição farmacêutica
|
AR092211A1
(es)
|
2012-09-24 |
2015-04-08 |
Merck Patent Ges Mit Beschränkter Haftung |
Derivados de hidropirrolopirrol
|
EP3590940B1
(fr)
|
2012-09-25 |
2021-06-09 |
F. Hoffmann-La Roche AG |
Dérivés du héxahydropyrrolo[3,4-c]pyrrole et composés similaires en tant qu'inhibiteurs de l'autotaxine (atx) et inhibiteurs de la production de l'acid lysophosphatidique (lpa) pour traiter des maladies rénales
|
MX357035B
(es)
|
2012-09-25 |
2018-06-25 |
Bayer Pharma AG |
Combinacion de regorafenib y acido acetilsalicilico para el tratamiento del cancer.
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
KR102189560B1
(ko)
|
2012-10-25 |
2020-12-11 |
테트라 디스커버리 파트너스 엘엘씨 |
Pde4 의 헤테로아릴 저해제
|
GEP201706691B
(en)
|
2012-12-31 |
2017-06-26 |
Cadila Healthcare Ltd |
Substituted phthalazin-1 (2h)-one derivatives as selecti- ve inhibitors of poly (adp-ribose) polymerase-1
|
WO2014133112A1
(fr)
|
2013-03-01 |
2014-09-04 |
国立大学法人東京大学 |
Dérivé imidazopyrimidinone substitué en position 8 présentant une activité inhibitrice de l'autotaxine
|
AR095079A1
(es)
|
2013-03-12 |
2015-09-16 |
Hoffmann La Roche |
Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
|
TWI593692B
(zh)
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
CN105026403B
(zh)
|
2013-03-12 |
2018-05-18 |
艾伯维公司 |
四环布罗莫结构域抑制剂
|
BR112015022041A2
(pt)
|
2013-03-12 |
2017-07-18 |
Acucela Inc |
derivados substituídos de 3-fenilpropilamina para o tratamento de doenças e distúrbios oftálmicas
|
AR095328A1
(es)
|
2013-03-15 |
2015-10-07 |
Biogen Idec Inc |
Agentes de modulación de s1p y/o atx
|
JP6424219B2
(ja)
|
2013-07-18 |
2018-11-14 |
ノバルティス アーゲー |
複素芳香環−ベンジル−アミド−サイクルコアを含むオートタキシン阻害剤
|
CA2927392C
(fr)
|
2013-10-17 |
2021-11-09 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs d'adn-pk
|
PT3071561T
(pt)
|
2013-11-22 |
2021-06-25 |
Sabre Therapeutics Llc |
Compostos inibidores de autotaxina
|
AR098475A1
(es)
|
2013-11-26 |
2016-06-01 |
Bayer Cropscience Ag |
Compuestos pesticidas y usos
|
MA38982A1
(fr)
|
2013-11-26 |
2017-09-29 |
Hoffmann La Roche |
Nouvel octahydro-cyclobuta [1,2-c; 3,4-c'] dipyrrol-2-yl
|
CN106103446B
(zh)
|
2014-03-26 |
2019-07-30 |
豪夫迈·罗氏有限公司 |
作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
WO2015144480A1
(fr)
|
2014-03-26 |
2015-10-01 |
Basf Se |
Composés d'imidazole et de [1,2,4]-triazole substitués utilisés comme fongicides
|
MX2016010675A
(es)
|
2014-03-26 |
2016-11-10 |
Hoffmann La Roche |
Compuestos condensados de [1,4]diazepina como inhibidores de produccion de la autotaxina (atx) y acido lisofosfatidico (lpa).
|
MD20160116A2
(ro)
|
2014-04-04 |
2017-04-30 |
X-Rx Discovery, Inc |
Inhibitori spirociclici substituiţi ai autotaxinei
|
EP3187492A4
(fr)
|
2014-08-29 |
2018-05-09 |
The University of Tokyo |
Dérivé de pyrimidone ayant une activité inhibitrice de l'autotaxine
|
HUE042335T2
(hu)
|
2014-10-14 |
2019-06-28 |
Vitae Pharmaceuticals Inc |
ROR-gamma dihidropirrolopiridin inhibitorai
|
SG11201706451TA
(en)
|
2015-02-15 |
2017-09-28 |
Hoffmann La Roche |
1-(het)arylsulfonyl-(pyrrolidine or piperidine)-2-carboxamide derivatives and their use as trpa1 antagonists
|
MA41898A
(fr)
|
2015-04-10 |
2018-02-13 |
Hoffmann La Roche |
Dérivés de quinazolinone bicyclique
|
CN104927727B
(zh)
|
2015-07-06 |
2017-01-11 |
香山红叶建设有限公司 |
一种玻璃幕墙用结构密封胶及其制备方法
|
PL415078A1
(pl)
|
2015-09-04 |
2017-03-13 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
|
CN108026077B
(zh)
|
2015-09-04 |
2021-11-05 |
豪夫迈·罗氏有限公司 |
苯氧基甲基衍生物
|
MA42923A
(fr)
|
2015-09-24 |
2021-04-28 |
Hoffmann La Roche |
Composés bicycliques comme inhibiteurs mixtes de atx/ca
|
JP6845230B2
(ja)
|
2015-09-24 |
2021-03-17 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
デュアルatx/ca阻害剤としての新規な二環式化合物
|
WO2017050792A1
(fr)
|
2015-09-24 |
2017-03-30 |
F. Hoffmann-La Roche Ag |
Composés bicycliques utilisés en tant qu'inhibiteurs d'atx
|
MA42918A
(fr)
|
2015-09-24 |
2018-08-01 |
Hoffmann La Roche |
Composés bicycliques utilisés en tant qu'inhibiteurs d'atx
|
TW201723176A
(zh)
|
2015-09-24 |
2017-07-01 |
Ionis製藥公司 |
Kras表現之調節劑
|
US10385057B2
(en)
|
2015-11-20 |
2019-08-20 |
Lundbeck La Jolla Research Center, Inc. |
Pyrazole compounds and methods of making and using same
|
US10323038B2
(en)
|
2015-11-20 |
2019-06-18 |
Abide Therapeutics, Inc. |
Pyrazole compounds and methods of making and using same
|
SG10201913450PA
(en)
|
2015-11-25 |
2020-03-30 |
Dana Farber Cancer Inst Inc |
Bivalent bromodomain inhibitors and uses thereof
|
BR112018007848B1
(pt)
|
2015-12-01 |
2021-12-21 |
Nihon Nohyaku Co., Ltd |
Composto de 3h-pirrolopiridina, n-óxido do mesmo ou um sal do mesmo, inseticida agrícola e hortícola compreendendo o composto e método para usar o mesmo
|
WO2017139978A1
(fr)
|
2016-02-19 |
2017-08-24 |
吴伟东 |
Procédé et système d'actualisation d'application de téléphone mobile
|
MA49879A
(fr)
|
2017-03-16 |
2020-06-24 |
Hoffmann La Roche |
Composés hétérocycliques utiles en tant qu'inhibiteurs doubles d'atx/ca
|
CN110382484B
(zh)
|
2017-03-16 |
2022-12-06 |
豪夫迈·罗氏有限公司 |
新的作为atx抑制剂的二环化合物
|
CN109311897B
(zh)
|
2017-03-20 |
2021-07-20 |
福马治疗股份有限公司 |
作为丙酮酸激酶(pkr)活化剂的吡咯并吡咯组合物
|